 Home > Active Ingredient News > Drugs Articles > Announcement of the Center for Drug Evaluation of the State Drug Administration on Issuing the "Technical Guidelines for the Detection of Minimal Residual Diseases in Clinical Trials of Chronic Myeloid Leukemia Drugs" (No. 43 of 2021)

Announcement of the Center for Drug Evaluation of the State Drug Administration on Issuing the "Technical Guidelines for the Detection of Minimal Residual Diseases in Clinical Trials of Chronic Myeloid Leukemia Drugs" (No. 43 of 2021)

 Last Update: 2021-12-08
 Source: Internet
 Author: User

Tags

pro drugs

food drug administration

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In order to encourage the development of new anti-tumor drugs, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation has organized and formulated the "Technical Guidelines for the Detection of Minimal Residual Diseases in Clinical Trials of Chronic Myeloid Leukemia Drugs" (see appendix)
.

In accordance with the requirements of the "Notice of the Comprehensive Department of the State Drug Administration on Issuing the Procedures for Issuing the Technical Guidelines for Drugs" (Yao Jian Zong Yao Guan [2020] No.

Hereby inform

Attachment: Technical guidelines for detection of minimal residual disease in clinical trials of chronic myeloid leukemia drugs

National Food and Drug Administration Center for Drug Evaluation

November 10, 2021

Relevant attachments

1 "Technical Guidelines for the Detection of Minimal Residual Diseases in Clinical Trials of Chronic Myeloid Leukemia Drugs".

1 "Technical Guidelines for the Detection of Minimal Residual Diseases in Clinical Trials of Chronic Myeloid Leukemia Drugs".
pdf

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Methyl-L-alanine3913-67-5

CAS No.: 3913-67-5

Industrial Grade

$1-1.04/KG FOB

High Purity 99% PEG MGF CAS 108174-48-7 Customized Peptides from China OUDA

CAS No.: 108174-48-7

Pharmacy Grade

$2-2.6/G FOB

Wholesales Purity 99 Peptides Powder Sema Tirz Retatrutide 5mg/10mg/15mg to Door From China

CAS No.: 2023788-19-2

Pharmacy Grade

$150-180/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.